whooping cough

Man holds his hand over his mouth while coughing into it
January 28, 2019

Nasal whooping cough vaccine trial underway at Vanderbilt

Vanderbilt vaccine researchers are enrolling adult volunteers in a National Institutes of Health (NIH)-sponsored Phase II clinical trial that will study a next generation pertussis vaccine that may protect people from whooping cough.

By Craig Boerner
July 9, 2015

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

By Matt Batcheldor
Person getting a shot
February 12, 2015

VU study explores optimal timing for pertussis vaccine

Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection.

By Jessica Pasley